Shagun Singh
Stock Analyst at RBC Capital
(3.40)
# 962
Out of 5,154 analysts
251
Total ratings
51.2%
Success rate
2.44%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Sector Perform | $115 → $125 | $113.31 | +10.32% | 24 | Feb 27, 2026 | |
| INSP Inspire Medical Systems | Maintains: Sector Perform | $90 → $68 | $62.99 | +7.95% | 10 | Feb 12, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $210 → $172 | $167.12 | +2.92% | 5 | Feb 10, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $130 → $115 | $71.35 | +61.18% | 19 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $240 → $255 | $240.40 | +6.07% | 24 | Feb 3, 2026 | |
| ABT Abbott Laboratories | Maintains: Outperform | $147 → $135 | $109.56 | +23.22% | 18 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Sector Perform | $355 → $374 | $338.64 | +10.44% | 16 | Jan 20, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $625 → $650 | $490.16 | +32.61% | 18 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $92 → $100 | $87.10 | +14.81% | 9 | Dec 17, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $81.64 | +22.49% | 24 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $370 → $380 | $237.01 | +60.33% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $118 | $90.90 | +29.81% | 22 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $22 → $17 | $3.18 | +434.59% | 14 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $111 → $101 | $94.11 | +7.32% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $68.10 | +24.82% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $21.14 | +18.26% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $364.56 | +19.32% | 19 | Jan 29, 2025 |
Teleflex
Feb 27, 2026
Maintains: Sector Perform
Price Target: $115 → $125
Current: $113.31
Upside: +10.32%
Inspire Medical Systems
Feb 12, 2026
Maintains: Sector Perform
Price Target: $90 → $68
Current: $62.99
Upside: +7.95%
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Sector Perform
Price Target: $210 → $172
Current: $167.12
Upside: +2.92%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $130 → $115
Current: $71.35
Upside: +61.18%
Johnson & Johnson
Feb 3, 2026
Maintains: Outperform
Price Target: $240 → $255
Current: $240.40
Upside: +6.07%
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $147 → $135
Current: $109.56
Upside: +23.22%
Penumbra
Jan 20, 2026
Downgrades: Sector Perform
Price Target: $355 → $374
Current: $338.64
Upside: +10.44%
Intuitive Surgical
Dec 17, 2025
Maintains: Outperform
Price Target: $625 → $650
Current: $490.16
Upside: +32.61%
Globus Medical
Dec 17, 2025
Maintains: Outperform
Price Target: $92 → $100
Current: $87.10
Upside: +14.81%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $81.64
Upside: +22.49%
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $237.01
Upside: +60.33%
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $90.90
Upside: +29.81%
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.18
Upside: +434.59%
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $94.11
Upside: +7.32%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $68.10
Upside: +24.82%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $21.14
Upside: +18.26%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $364.56
Upside: +19.32%